Researchers find new chemotherapy combination shows promise in endometrial cancer

Researchers from The University of Texas M. D. Anderson Cancer Centre report that in a small study of women with advanced or recurrent endometrial cancer, gemcitabine and cisplatin, when used in combination, produced a response rate in fifty percent of patients...

Read the whole article on

More from